abstract |
The present invention relates to a vaccine composition comprising at least one human immunodeficiency virus (HIV) antigen and one or both of the following antigens: i) at least one herpes simplex virus (HSV) antigen and ii) at least one human papillomavirus (HPV) antigen. The invention also relates to a process for the preparation of novel vaccine compositions. SHE |